These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 34903958)

  • 1. Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines.
    Sun Z; Sun X; Chen Z; Du J; Wu Y
    Int J Pept Res Ther; 2022; 28(1):19. PubMed ID: 34903958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy.
    Starska-Kowarska K
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine in head and neck cancer.
    Kaidar-Person O; Gil Z; Billan S
    Drug Resist Updat; 2018 Sep; 40():13-16. PubMed ID: 30466712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
    Solomon B; Young RJ; Rischin D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for HPV negative head and neck squamous cell carcinoma.
    Jiang B; Elkashif A; Coulter JA; Dunne NJ; McCarthy HO
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189138. PubMed ID: 38889878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review.
    Afshari K; Sohal KS
    Cancer Control; 2023; 30():10732748231185003. PubMed ID: 37328298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
    Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising systemic immunotherapies in head and neck squamous cell carcinoma.
    Gildener-Leapman N; Ferris RL; Bauman JE
    Oral Oncol; 2013 Dec; 49(12):1089-96. PubMed ID: 24126223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma.
    Bann DV; Deschler DG; Goyal N
    Cancers (Basel); 2016 Sep; 8(10):. PubMed ID: 27669306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models.
    Liew YX; Karen-Ng LP; Vincent-Chong VK
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck cancer: Current challenges and future perspectives.
    Bhat GR; Hyole RG; Li J
    Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
    Muzaffar J; Bari S; Kirtane K; Chung CH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects.
    Gao L; Zhang A; Yang F; Du W
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlate the
    Lyu H; Li M; Jiang Z; Liu Z; Wang X
    Comput Struct Biotechnol J; 2019; 17():1020-1030. PubMed ID: 31428295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
    Kumai T; Matsuda Y; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Celis E; Kobayashi H
    Br J Cancer; 2013 Oct; 109(8):2155-66. PubMed ID: 24045666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy for head and neck squamous cell carcinoma microenvironment.
    Guo Z; Li K; Liu P; Zhang X; Lv J; Zeng X; Zhang P
    Front Med (Lausanne); 2023; 10():1257898. PubMed ID: 37711747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Immunology and HPV.
    Wollenberg B
    Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect.
    Zhang Y; Sun X
    Onco Targets Ther; 2020; 13():10207-10220. PubMed ID: 33116602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.